openPR Logo
Press release

Pertussis Vaccine Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players

04-13-2022 05:41 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research

/ PR Agency: QY Research
The QY Research released a latest market research report on the Global Pertussis Vaccine market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/348594/pertussis-vaccine

Summary

Market Analysis and Insights: Global Pertussis Vaccine Market

The global Pertussis Vaccine market was valued at US$ 5043.53 million in 2020 and will reach US$ 6376.78 million by the end of 2027, growing at a CAGR of 3.50% during 2021-2027.

.

The report mentions the prominent market player consisting of:

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

Pertussis Vaccine Market Segment by Type

Acellular Vaccines

Whole-cell Vaccines

Pertussis Vaccine Market Segment by Application

12 Months Below

12 Months Above

The report on the Pertussis Vaccine market covers the following region (country) analysis:

North America

Europe

China

Japan

India

Asia-Pacific Other

Rest of World

 

 

The Goal of the Report

To study and analyze the global Pertussis Vaccineconsumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Pertussis Vaccinemarket by identifying its various subsegments.
Focuses on the key global Pertussis Vaccinemanufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pertussis Vaccinewith respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Pertussis Vaccinesubmarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Target Audience

> Pertussis Vaccine companies

> Research organizations

> Government Organizations

> Research/Consultancy firms

Table of Contents

 

1 PERTUSSIS VACCINE MARKET OVERVIEW 1
1.1 Pertussis Vaccine Product Scope 1
1.2 Pertussis Vaccine Segment by Type 1
1.2.1 Global Pertussis Vaccine Revenue by Type (2016 & 2021 & 2027) 2
1.2.2 Acellular Vaccines 2
1.2.3 Whole-cell Vaccines 3
1.3 Pertussis Vaccine Segment by Application 4
1.3.1 Global Pertussis Vaccine Revenue Comparison by Application (2016 & 2021 & 2027) 4
1.3.2 12 Months Below 5
1.3.3 12 Months Above 6
1.4 Global Pertussis Vaccine Market Estimates and Forecasts (2016-2027) 7
1.4.1 Global Pertussis Vaccine Market Size in Value Growth Rate (2016-2027) 7
1.4.2 Global Pertussis Vaccine Market Size in Volume Growth Rate (2016-2027) 9
1.4.3 Global Pertussis Vaccine Price Trends (2016-2027) 10

2 PERTUSSIS VACCINE ESTIMATES AND FORECASTS BY REGION 11
2.1 Global Pertussis Vaccine Market Size by Region: 2016 VS 2021 VS 2027 11
2.2 Global Pertussis Vaccine Retrospective Market Scenario by Region (2016-2021) 12
2.2.1 Global Pertussis Vaccine Sales Market Share by Region (2016-2021) 12
2.2.2 Global Pertussis Vaccine Revenue Market Share by Region (2016-2021) 13
2.3 Global Pertussis Vaccine Market Estimates and Forecasts by Region (2022-2027) 15
2.3.1 Global Pertussis Vaccine Sales Estimates and Forecasts by Region (2022-2027) 15
2.3.2 Global Pertussis Vaccine Revenue Forecast by Region (2022-2027) 16
2.4 Geographic Market Analysis: Market Facts & Figures 18
2.4.1 North America Pertussis Vaccine Estimates and Projections (2016-2027) 18
2.4.2 Europe Pertussis Vaccine Estimates and Projections (2016-2027) 20
2.4.3 China Pertussis Vaccine Estimates and Projections (2016-2027) 22
2.4.4 Japan Pertussis Vaccine Estimates and Projections (2016-2027) 24
2.4.5 India Pertussis Vaccine Estimates and Projections (2016-2027) 26
2.4.6 Asia-Pacific Other Pertussis Vaccine Estimates and Projections (2016-2027) 28

3 PERTUSSIS VACCINE COMPETITION LANDSCAPE BY PLAYERS 30
3.1 Global Pertussis Vaccine Players by Sales (2016-2021) 30
3.2 Global Pertussis Vaccine Players by Revenue (2016-2021) 31
3.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2020) 33
3.4 Global Pertussis Vaccine Average Price by Company (2016-2021) 34
3.5 Pertussis Vaccine Manufacturers Headquarters 34

4 PERTUSSIS VACCINE MARKET SIZE BY TYPE 35
4.1 Global Pertussis Vaccine Historic Market Review by Type (2016-2021) 35
4.1.1 Global Pertussis Vaccine Sales Market Share by Type (2016-2021) 35
4.1.2 Global Pertussis Vaccine Revenue Market Share by Type (2016-2021) 36
4.1.3 Global Pertussis Vaccine Price by Type (2016-2021) 37
4.2 Global Pertussis Vaccine Market Estimates and Forecasts by Type (2022-2027) 38
4.2.1 Global Pertussis Vaccine Sales Forecast by Type (2022-2027) 38
4.2.2 Global Pertussis Vaccine Revenue Forecast by Type (2022-2027) 38
4.2.3 Global Pertussis Vaccine Price Forecast by Type (2022-2027) 39

5 GLOBAL PERTUSSIS VACCINE MARKET SIZE BY APPLICATION 40
5.1 Global Pertussis Vaccine Historic Market Review by Application (2016-2021) 40
5.1.1 Global Pertussis Vaccine Sales Market Share by Application (2016-2021) 40
5.1.2 Global Pertussis Vaccine Revenue Market Share by Application (2016-2021) 41
5.1.3 Global Pertussis Vaccine Price by Application (2016-2021) 42
5.2 Global Pertussis Vaccine Market Estimates and Forecasts by Application (2022-2027) 43
5.2.1 Global Pertussis Vaccine Sales Forecast by Application (2022-2027) 43
5.2.2 Global Pertussis Vaccine Revenue Forecast by Application (2022-2027) 43
5.2.3 Global Pertussis Vaccine Price Forecast by Application (2022-2027) 44

6 NORTH AMERICA PERTUSSIS VACCINE MARKET FACTS & FIGURES 45
6.1 North America Pertussis Vaccine Sales by Company 45
6.1.1 North America Pertussis Vaccine Sales by Company (2016-2021) 45
6.1.2 North America Pertussis Vaccine Sales Market Share by Company (2016-2021) 45
6.2 North America Pertussis Vaccine Sales Breakdown by Type 45
6.2.1 North America Pertussis Vaccine Sales Breakdown by Type (2016-2021) 45
6.2.2 North America Pertussis Vaccine Sales Breakdown by Type (2022-2027) 46
6.3 North America Pertussis Vaccine Sales Breakdown by Application 47
6.3.1 North America Pertussis Vaccine Sales Breakdown by Application (2016-2021) 47
6.3.2 North America Pertussis Vaccine Sales Breakdown by Application (2022-2027) 48

7 EUROPE PERTUSSIS VACCINE MARKET FACTS & FIGURES 49
7.1 Europe Pertussis Vaccine Sales by Company 49
7.1.1 Europe Pertussis Vaccine Sales by Company (2016-2021) 49
7.1.2 Europe Pertussis Vaccine Sales Market Share by Company (2016-2021) 49
7.2 Europe Pertussis Vaccine Sales Breakdown by Type 49
7.2.1 Europe Pertussis Vaccine Sales Breakdown by Type (2016-2021) 49
7.2.2 Europe Pertussis Vaccine Sales Breakdown by Type (2022-2027) 50
7.3 Europe Pertussis Vaccine Sales Breakdown by Application 51
7.3.1 Europe Pertussis Vaccine Sales Breakdown by Application (2016-2021) 51
7.3.2 Europe Pertussis Vaccine Sales Breakdown by Application (2022-2027) 52

8 CHINA PERTUSSIS VACCINE MARKET FACTS & FIGURES 53
8.1 China Pertussis Vaccine Sales by Company 53
8.1.1 China Pertussis Vaccine Sales by Company (2016-2021) 53
8.1.2 China Pertussis Vaccine Sales Market Share by Company (2016-2021) 53
8.2 China Pertussis Vaccine Sales Breakdown by Type 54
8.2.1 China Pertussis Vaccine Sales Breakdown by Type (2016-2021) 54
8.2.2 China Pertussis Vaccine Sales Breakdown by Type (2022-2027) 55
8.3 China Pertussis Vaccine Sales Breakdown by Application 55
8.3.1 China Pertussis Vaccine Sales Breakdown by Application (2016-2021) 55
8.3.2 China Pertussis Vaccine Sales Breakdown by Application (2022-2027) 56

9 JAPAN PERTUSSIS VACCINE MARKET FACTS & FIGURES 57
9.1 Japan Pertussis Vaccine Sales by Company 57
9.1.1 Japan Pertussis Vaccine Sales by Company (2016-2021) 57
9.1.2 Japan Pertussis Vaccine Sales Market Share by Company (2016-2021) 57
9.2 Japan Pertussis Vaccine Sales Breakdown by Type 57
9.2.1 Japan Pertussis Vaccine Sales Breakdown by Type (2016-2021) 57
9.2.2 Japan Pertussis Vaccine Sales Breakdown by Type (2022-2027) 58
9.3 Japan Pertussis Vaccine Sales Breakdown by Application 59
9.3.1 Japan Pertussis Vaccine Sales Breakdown by Application (2016-2021) 59
9.3.2 Japan Pertussis Vaccine Sales Breakdown by Application (2022-2027) 60

10 INDIA PERTUSSIS VACCINE MARKET FACTS & FIGURES 61
10.1 India Pertussis Vaccine Sales by Company 61
10.1.1 India Pertussis Vaccine Sales by Company (2016-2021) 61
10.1.2 India Pertussis Vaccine Sales Market Share by Company (2016-2021) 61
10.2 India Pertussis Vaccine Sales Breakdown by Type 61
10.2.1 India Pertussis Vaccine Sales Breakdown by Type (2016-2021) 61
10.2.2 India Pertussis Vaccine Sales Breakdown by Type (2022-2027) 62
10.3 India Pertussis Vaccine Sales Breakdown by Application 63
10.3.1 India Pertussis Vaccine Sales Breakdown by Application (2016-2021) 63
10.3.2 India Pertussis Vaccine Sales Breakdown by Application (2022-2027) 64

11 ASIA-PACIFIC OTHER PERTUSSIS VACCINE MARKET FACTS & FIGURES 65
11.1 Asia-Pacific Other Pertussis Vaccine Sales by Company 65
11.1.1 Asia-Pacific Other Pertussis Vaccine Sales by Company (2016-2021) 65
11.1.2 Asia-Pacific Other Pertussis Vaccine Sales Market Share by Company (2016-2021) 65
11.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type 65
11.2.1 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type (2016-2021) 65
11.2.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Type (2022-2027) 66
11.3 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application 67
11.3.1 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application (2016-2021) 67
11.3.2 Asia-Pacific Other Pertussis Vaccine Sales Breakdown by Application (2022-2027) 68

12 COMPANY PROFILES AND KEY FIGURES IN PERTUSSIS VACCINE BUSINESS 69
12.1 Sanofi Pasteur 69
12.1.1 Sanofi Pasteur Corporation Information 69
12.1.2 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 69
12.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered 70
12.2 GSK 71
12.2.1 GSK Corporation Information 71
12.2.2 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 71
12.2.3 GSK Pertussis Vaccine Products Offered 72
12.3 Mitsubishi Tanabe Pharma 72
12.3.1 Mitsubishi Tanabe Pharma Corporation Information 72
12.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 73
12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered 73
12.4 KM Biologics 74
12.4.1 KM Biologics Corporation Information 74
12.4.2 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 74
12.4.3 KM Biologics Pertussis Vaccine Products Offered 75
12.5 Wuhan Institute of Biological Products 75
12.5.1 Wuhan Institute of Biological Products Corporation Information 75
12.5.2 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 76
12.5.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered 76
12.6 Walvax Biotechnology 77
12.6.1 Walvax Biotechnology Corporation Information 77
12.6.2 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 78
12.6.3 Walvax Biotechnology Pertussis Vaccine Products Offered 78
12.7 Chengdu Institute of Biological Products 79
12.7.1 Chengdu Institute of Biological Products Corporation Information 79
12.7.2 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 79
12.7.3 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered 79
12.8 Minhai Biotechnology 80
12.8.1 Minhai Biotechnology Corporation Information 80
12.8.2 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2016-2021) 81
12.8.3 Minhai Biotechnology Pertussis Vaccine Products Offered 81

13 PERTUSSIS VACCINE MANUFACTURING COST ANALYSIS 82
13.1 Pertussis Vaccine Key Raw Materials Analysis 82
13.2 Proportion of Manufacturing Cost Structure 83
13.3 Manufacturing Process Analysis of Pertussis Vaccine 83

14 MARKETING CHANNEL AND DISTRIBUTORS 85
14.1 Marketing Channel 85
14.2 Pertussis Vaccine Distributors List 86

15 MARKET DYNAMICS 89
15.1 Pertussis Vaccine Market Trends 89
15.2 Pertussis Vaccine Opportunities and Drivers 89
15.3 Pertussis Vaccine Market Challenges 89
15.4 Porter's Five Forces Analysis 90

16 RESEARCH FINDINGS AND CONCLUSION 91

17 APPENDIX 92
17.1 Research Methodology 92
17.1.1 Methodology/Research Approach 92
17.1.2 Data Source 95
17.2 Author Details 98
17.3 Disclaimer 98

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/348594/pertussis-vaccine

Any doubts and questions will be welcome.

Customization of the Report:

This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

Contact Us

QY Research

E-mail: global@qyresearch.com

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

The QY Research released a latest market research report on the Global Pertussis Vaccine market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Pertussis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pertussis Vaccine Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players here

News-ID: 2601595 • Views:

More Releases from QY Research

Global and U.S. Hydrogen Odorants Market Report, Published by QY Research.
Global and U.S. Hydrogen Odorants Market Report, Published by QY Research.
Hydrogen Odorants are chemical additives introduced into hydrogen gas streams to impart a detectable smell for leak detection and safety monitoring, since pure hydrogen is colorless and odorless. Effective odorants must provide distinct olfactory signals at very low concentrations, while maintaining compatibility with fuel cells, pipelines, and storage systems. Common candidates include sulfur-free organic compounds, terpenes, and nitrogen-containing molecules, developed as alternatives to natural gas odorants to prevent catalyst poisoning
Global and U.S. 3-point / 4-point Bend Fixtures Market Report, Published by QY Research.
Global and U.S. 3-point / 4-point Bend Fixtures Market Report, Published by QY R …
3-point and 4-point Bend Fixtures are mechanical test assemblies designed to evaluate the flexural strength, stiffness, and fracture behavior of materials under bending loads. In a 3-point setup, the specimen is supported at two points with a single load applied at the midpoint, while the 4-point configuration distributes the load between two points for a more uniform stress region. These fixtures are widely used for plastics, composites, ceramics, metals, and
Global and U.S. High Speed Flatbed Scanners Market Report, Published by QY Research.
Global and U.S. High Speed Flatbed Scanners Market Report, Published by QY Resea …
High Speed Flatbed Scanners are digital imaging devices designed to capture high-resolution scans of documents, photos, and bound materials with rapid throughput compared to standard flatbed units. Featuring advanced CCD/CIS sensors, duplex scanning, and automatic image correction software, they are essential for businesses, government agencies, libraries, and archival institutions managing large volumes of physical records. https://www.qyresearch.com/reports/4942701/high-speed-flatbed-scanners The global High Speed Flatbed Scanners market reached USD 2.2 billion in 2024, growing at a
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Globally
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Glo …
Steel floor panels cover a range of products used in commercial, industrial and data-center construction: profiled steel decking for composite slabs, galvanized or coated steel raised-access panels for server rooms and offices, and engineered steel mezzanine/industrial floor panels for warehouses and manufacturing plants. They are selected for strength-to-weight ratio, speed of installation, fire performance (when specified with appropriate infill), recyclability and long service life. Product differentiation is driven by profile

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion